New asthma drug enters human testing
NCT ID NCT07245368
Summary
This study is testing a new drug called PRA-216 to see if it is safe and can help control asthma. First, healthy volunteers will receive the drug to check for safety. Then, people with mild-to-moderate asthma will receive it to see if it reduces inflammation in their airways. The goal is to find a new treatment option for managing asthma symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emeritus Research Camberwell
NOT_YET_RECRUITINGCamberwell, Victoria, 3124, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emertitus Research Sydney
NOT_YET_RECRUITINGBotany, New South Wales, 2019, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Linear
NOT_YET_RECRUITINGJoondalup, Western Australia, 6027, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Linear
RECRUITINGNedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PCRN Waikato, Nawton
NOT_YET_RECRUITINGHamilton, Auckland, 3200, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PCRN Wellington, Ebdentown
NOT_YET_RECRUITINGUpper Hutt, Auckland, 5018, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pacific Clinical Research Network-Auckland
NOT_YET_RECRUITINGTakapuna, Auckland, 0622, New Zealand
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.